ClinicalTrials.gg
Active, not recruitingNCT06913517Updated Apr 6, 2025

Effect of Hearing Aid Versus Cochlear Implant on Hearing and Speech Recognition in Children

An observational study in Speech Disorders, sponsored by Superior University. Active, not recruiting at 1 site in Pakistan. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-04-06.

Sponsored by Superior University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
26
Ages
6 Years to 18 Years
Sex
All
01

Study summary

This study examines the comparative effects of hearing aids and cochlear implants on hearing and speech recognition in children with hearing loss.

This research adopts a quantitative approach to compare the outcomes of children using hearing aids versus cochlear implants. Data will be collected through audiological evaluations, including aided audiometry and speech recognition tests conducted in an audiology clinic. Descriptive and inferential statistical analyses will be used to determine differences between the groups.

Read the detailed description

The study aims to provide evidence-based guidance for audiologists, educators, and caregivers regarding optimal device selection and management. By identifying the strengths and limitations of each intervention, the findings will contribute to improved rehabilitation strategies, ultimately enhancing auditory and speech outcomes in children with hearing loss. This research holds significance for advancing clinical practices in pediatric audiology.

02

Conditions studied

  • Speech Disorders

Browse trials for

03

In context

Speech Disorders

77 studies on the registry are indexed under Speech Disorders; 20 are open to participants now.

This study's enrollment of 26 is below the median of 50 across 23 observational studies indexed under Speech Disorders.

Browse Speech Disorders studies →

Lead sponsor

Superior University is the lead sponsor of 253 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study examines the comparative effects of hearing aids and cochlear implants on hearing and speech recognition in children with hearing loss.

This research adopts a quantitative approach to compare the outcomes of children using hearing aids versus cochlear implants. Data will be collected through audiological evaluations, including aided audiometry and speech recognition tests conducted in an audiology clinic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children with 6-18 years of age
  • Bilateral hearing aid users with Moderate to Severe degree Sensorineural hearing loss.
  • Unilateral Cochlear Implant users with Severe to Profound degree Sensorineural hearing loss and no amplification to other ear.
  • Consistent use of hearing aid or cochlear implant for more than 1 year.
  • Known or presumed early onset of hearing loss before 3 years of age
  • Urdu as primary language of education
  • Enrolled in rehabilitation program (school or pre-school for hearing impaired children) focused on oral communication.

Exclusion criteria

Exclusion Criteria:

  • Children below 6 years or above 18 years
  • Children with less than 1 year of consistent use of hearing aids or cochlear implant
  • Children with cognitive, neurological or developmental disorders."
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
26 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Aided Audiometry

    the hearing ability of individual using hearing aids or cochlear implant is measured in a Free Field Testing Environment using Pure Tones at frequencies 250Hz to 8000Hz. Interpretation: Results are plotted on Audiogram, showing the lowest level in decibel (dB HL) at which patient can detect sounds with their hearing aid or cochlear implant. 20-30dB HL Excellent aided thresholds (satisfactory) 31-40 dBHL Mild aided thresholds (good) 41-60 dBHL Moderate aided hearing thresholds (average) More than 60dBHL Severe aided hearing thresholds (poor)

    Time frame: 12 Months

  2. Speech Perception Test

    Evaluated using Phonetically Balanced Monosyllabic word list in Urdu in both quiet and noisy environment. Interpretation: The score is expressed as a percentage of correctly identified words under specified listening condition. 90- 100% Normal or Slight difficulty 70-89% Mild difficulty 50-69% Moderate difficulty Below 50% Severe difficulty or poor word recognition Score

    Time frame: 12 Months

07

Study locations

1 site
  • Society for Audiological and Developmental Ailments (SADA) - Audiology Clinic
    Lahore, Punjab, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Jun 2025, 3 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 29, 2025
First posted
Apr 6, 2025
StartActual
Mar 20, 2025
Primary completionEst.
Jun 20, 2025
CompletionEst.
Feb 20, 2026
Last update
Apr 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06913517
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
Apr 6, 2025
Start date
Mar 20, 2025
Primary completion
Jun 20, 2025 (estimated)
Completion
Feb 20, 2026 (estimated)
Last update
Apr 6, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion